Indeed, TBK1 could interact with CEP170 and NuMA in H1650 NSCLC cells (Fig. 5b) and this interaction was augmented during mitosis and abolished by treatment with BX795 (Fig. 5c). Here, TBK1 is linked to non-small cell lung carcinoma.